ESPE Abstracts (2018) 89 P-P3-262

ESPE2018 Poster Presentations Growth & Syndromes P3 (51 abstracts)

Deletion of 12q12 Increases the Risk of Growth Retardation and Intellectual Disability

Ying Weng , Xiaoping Luo & Ling Hou


Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China


Single-nucleotide polymorphism (SNP) arrays have been widely used to identify novel genomic imbalances. Many of these genomic imbalances have been confirmed to interact with developmental delays, intellectual disabilities and congenital defects. Here, we identified a Chinese girl with a 3.18 Mb deletion at 12q12 (human genome build 19: 43,418,911–46,601,627). Deletions at 12q12 are extremely rare chromosomal imbalances; only five cases involving a deletion of this type have previously been reported. In these six sporadic cases, all of the patients exhibited developmental issues accompanied by different degrees of intellectual disability. A review of DECIPHER patient data revealed an additional 10 cases involving genomic deletion at 12q12. Many of the patients in these cases exhibited developmental delay and intellectual disability. When these patients were included, 88% and 69% of individuals with a deletion in this chromosomal region presented with developmental retardation and intellectual defects, respectively. Database searches indicated that this copy number variant (CNV) has not been found in normal humans. Therefore, we suggest that a CNV in this region is a risk factor for developmental retardation and intellectual disability.

Volume 89

57th Annual ESPE (ESPE 2018)

Athens, Greece
27 Sep 2018 - 29 Sep 2018

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.